Innova Captab Ltd. (INNOVACAP): Innova Captab Share Price rises 2.88% near 52-week high
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Innova Captab Share Price is trading at Rs 1,214.70, up 2.88% today, and remains close to its 52-week high. The company’s market capitalisation stands at Rs 6,756.83 crore, keeping Innova Captab Ltd. (INNOVACAP) in focus in Healthcare stock news.
Innova Captab Share Price is trading at Rs 1,214.70 on 21 September 2026 at 9:48 AM IST, up Rs 33.95 from the previous close of Rs 1,180.75. The stock is moving within sight of its 52-week high, with a day high of Rs 1,225.35 and a market capitalisation of Rs 6,756.83 crore. For readers tracking Innova Captab Share Price Today, the latest move places the stock in a near-high event without implying that it has set a new yearly high.
Innova Captab Share Price Today: Price Action Analysis
The latest Univest data shows that the price action is straightforward: the stock opened at Rs 1,173.90, held the same level as the day low, and moved to Rs 1,225.35 intraday. Turnover stood at Rs 0.32 crore. In Innova Captab Stock News, the event matters because the share price is trading near its 52-week peak, while the available financial ratios and earnings figures provide context for how the market is valuing the business. The article below covers Innova Captab Share Price Today, fundamental analysis, sector comparison and peer positioning in one place.
| Metric | Value |
|---|---|
| Current Price | Rs 1,214.7 |
| Previous Close | Rs 1,180.75 |
| Today's Move | +Rs 33.95 (+2.88%) |
| Open | Rs 1,173.9 |
| High | Rs 1,225.35 |
| Low | Rs 1,173.9 |
| Turnover | Rs 0.32 crore |
| Market Capitalisation | Rs 6,756.83 crore |
Innova Captab Ltd. (INNOVACAP) traded at Rs 1,214.7 versus the previous close of Rs 1,180.75, a rise of 2.88%. The stock opened at Rs 1,173.9, reached a high of Rs 1,225.35 and touched a low of Rs 1,173.9.
Innova Captab Share Price moved higher by Rs 33.95 from the previous close, with a day change of 2.88%. The stock opened at Rs 1,173.90, stayed at that level as the day low, and touched Rs 1,225.35 as the day high, which keeps it close to the 52-week high zone. This makes the latest Innova Captab Share Price Today movement important for traders and investors following Stock Market Today screens for 52 Week High Stocks.
The current price of Rs 1,214.70 sits above the opening level and close to the intraday high, while turnover of Rs 0.32 crore shows the value traded during the market update. Since the price remains near its yearly high, the latest Innova Captab Share Price update is being watched as part of broader Share Market Today and Market News coverage. The key factual point is that the stock is holding near its upper range for the day, and the latest movement confirms the near-52-week-high event for Innova Captab Share Price without adding any company-specific catalyst.
Innova Captab Ltd. (INNOVACAP) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,756.83 crore |
| P/E Ratio | 43.23x |
| P/B Ratio | 5.95x |
| ROE | 13.75% |
| ROCE | 15.04% |
| EPS | Rs 27.31 |
| Book Value Per Share | Rs 198.33 |
| Dividend Yield | 0.17% |
Innova Captab Ltd. (INNOVACAP) fundamental metrics show P/E 43.23x, P/B 5.95x, ROE 13.75%, ROCE 15.04%. These figures provide context only and are not a buy or sell signal.
Innova Captab Ltd. has a market capitalisation of Rs 6756.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.23x, P/B at 5.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.75% and ROCE of 15.04%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 27.31, book value per share of Rs 198.33, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.23x |
| Benchmark Median P/E | 28.19x |
| Benchmark Average P/E | 40.39x |
| Benchmark P/E Range | 0x to 683.5x |
| Company P/B Ratio | 5.95x |
| Benchmark Median P/B | 3x |
| Company ROE | 13.75% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 15.04% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 6,756.83 crore |
| Benchmark Median Market Cap | Rs 677.56 crore |
Innova Captab Ltd. (INNOVACAP) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Innova Captab Ltd. (INNOVACAP) has a P/E ratio of 43.23x, which is above the benchmark median of 28.19x, a difference of +53.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Innova Captab Ltd. (INNOVACAP) has a ROE of 13.75%, which is above the benchmark median of 11.69%, a difference of +17.62%. Innova Captab Ltd. (INNOVACAP) has a ROCE of 15.04%, which is above the benchmark median of 13.32%, a difference of +12.91%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Morepen Laboratories Ltd. | MOREPENLAB | 6,624.76 | 47.14 | 5.09 | 7.96 | 10.19 |
| SYMBIOTEC PHARMALAB LTD | SYMBIOTEC | 7,024.8 | 63.92 | 4.73 | 11.22 | 12.41 |
| SENORES PHARMACEUTICALS L | SENORES | 6,474.21 | 51.23 | 6.72 | 14.14 | 15.66 |
| Sanofi India Ltd. | SANOFI | 7,111.86 | 21.96 | 8.61 | 44.5 | 55.46 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,234.73 | 53.12 | 5.87 | 12.11 | 17.4 |
Innova Captab Ltd. (INNOVACAP) has a P/E ratio of 43.23x compared with the displayed peer median of 51.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.75% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 15.04% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Innova Captab Ltd. (INNOVACAP) has a market capitalisation of Rs 6,756.83 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Innova Captab
- Innova Captab Share Price is trading at Rs 1,214.70, up 2.88% from the previous close.
- The stock’s day high of Rs 1,225.35 keeps it near the 52-week high zone.
- Market capitalisation stands at Rs 6,756.83 crore, a key size reference for the name.
- P/E is 43.23, P/B is 5.95, ROE is 13.75% and ROCE is 15.04%.
- Revenue for Jun 2026 was Rs 4,708.52 crore, with net profit at Rs 441.26 crore.
About Innova Captab
Innova Captab Ltd. (INNOVACAP) operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is listed on NSE and BSE, and the current market capitalisation places it at Rs 6,756.83 crore. For readers tracking Innova Captab Share Price, this classification is useful because the stock is being assessed within a clearly defined healthcare and pharma peer set. Innova Captab Share Price Today therefore combines a near-high price event with a valuation profile that can be compared against industry benchmarks and listed peers.
Frequently Asked Questions
Why is Innova Captab Share Price in focus today?
What is Innova Captab Share Price Today?
Ans. Innova Captab Share Price Today is Rs 1,214.70. The stock is up Rs 33.95 from the previous close of Rs 1,180.75, with the day high at Rs 1,225.35 and the day low at Rs 1,173.90.
Is Innova Captab near its 52-week high?
Ans. Yes. Innova Captab Share Price is trading close to its 52-week high, with an intraday high of Rs 1,225.35. That makes the stock relevant for readers following 52 Week High Stocks and related market screens.
What does the valuation of Innova Captab Share Price show?
Ans. Innova Captab Share Price is supported by a P/E ratio of 43.23 and a P/B ratio of 5.95. Those figures sit above the same-industry median, which places the stock in a higher valuation band.
How do ROE and ROCE look for Innova Captab?
Ans. ROE stands at 13.75% and ROCE at 15.04%. Both are above the same-industry median values, which gives useful context for Innova Captab Share Price alongside the current valuation multiples.
What are the latest earnings and revenue figures?
Ans. Revenue for Jun 2026 was Rs 4,708.These figures help frame Innova Captab Share Price against the company’s latest reported operating performance.
How does Innova Captab compare with peers?
Ans. Innova Captab Share Price compares with peers such as Morepen Laboratories, SYMBIOTEC PHARMALAB and SENORES. Its P/E is below some peer readings, while ROE and ROCE are stronger than several names in the set.
Where can investors track Innova Captab Share Price?
Ans. Investors can track Innova Captab Share Price on Univest for live price updates, valuation ratios, earnings metrics, 52-week levels and peer comparison. That makes it a useful reference for Innova Captab Share News and Stock News.
Track Innova Captab Share Price on Univest
Use Innova Captab Ltd. (INNOVACAP) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Innova Captab Share Price on Univest for live price updates, 52-week levels, valuation ratios, market capitalisation, earnings metrics, sector context and peer comparison. Univest also helps follow Innova Captab Share News and Innova Captab Stock News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
